Role of COVID-19 Vaccine in the Management of Gynecologic Oncology Lymphadenopathies.
Laura Fernandez SanahujaEster MiralpeixJosep Maria Solé SedeñoMarta BaucellsBerta FabregoAna SierraGemma ManceboPublished in: International journal of environmental research and public health (2024)
COVID-19 vaccine does not increase the incidence of lymphadenopathies in imaging tests of gynecological cancer patients.